for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes. The MIRACL Study: A randomized controlled Trial. - Schwartz,G.G.; Olsson,A.G.; Ezekowitz,P. (The Journal of the American Medical Association, 2001)